Sun Pharma recalls allergy drug in the US

The Pharma major is recalling over 10 lakh boxes of its anti-allergic Loratadine drug from the US market.


The recall has been put under Class-III

As per the information available on the US Food and Drug Administration's (US FDA)website, Ohm Laboratories, a unit of Ranbaxy Laboratories, is recalling 10,85,095 boxes for being "Superpotent Drug: Out Of Specification."

Sun Pharma had acquired Ranbaxy in a $4-billion deal last year.

The recall was initiated on July 28 this year and has been put under Class-III which the US FDA defines as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences."



Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email